Q4 2015 13F Holders as of 12/31/2015
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
71.9M
-
Number of holders
-
242
-
Total 13F shares, excl. options
-
65.6M
-
Shares change
-
-196K
-
Total reported value, excl. options
-
$3.95B
-
Value change
-
-$8.12M
-
Put/Call ratio
-
0
-
Number of buys
-
97
-
Number of sells
-
-116
-
Price
-
$60.22
Significant Holders of WEST PHARMACEUTICAL SERVICES INC - Common Stock (WST) as of Q4 2015
263 filings reported holding WST - WEST PHARMACEUTICAL SERVICES INC - Common Stock as of Q4 2015.
WEST PHARMACEUTICAL SERVICES INC - Common Stock (WST) has 242 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 65.6M shares
of 71.9M outstanding shares and own 91.17% of the company stock.
Largest 10 shareholders include PRICE T ROWE ASSOCIATES INC /MD/ (8.58M shares), VANGUARD GROUP INC (5.32M shares), Neuberger Berman Group LLC (4.8M shares), FRANKLIN RESOURCES INC (4.03M shares), BlackRock Fund Advisors (3.61M shares), STATE STREET CORP (3.28M shares), BAMCO INC /NY/ (2.37M shares), BlackRock Institutional Trust Company, N.A. (2.03M shares), RS INVESTMENT MANAGEMENT CO LLC (1.92M shares), and KALMAR INVESTMENTS INC /DE/ (1.45M shares).
This table shows the top 242 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.